Organization · Venture Capital
VP Venture Partners
VP Venture Partners is a Zurich-based venture capital firm that invests in early-stage life sciences companies across Europe, focusing on medical innovations and technologies. They provide hands-on support to startups in areas with high unmet medical needs.
Overview
What VP Venture Partners does
What VP Venture Partners is
VP Venture Partners is a Zurich-based venture capital firm that invests in early-stage life sciences companies across Europe, focusing on medical innovations and technologies. They provide hands-on support to startups in areas with high unmet medical needs.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find VP Venture Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
VP Venture Partners as a funder
Investment thesis
VP Venture Partners focuses on early-stage life science companies in Europe, emphasizing deep tech ventures that address unmet needs with high patient impact.
Focus narrative
The firm invests primarily in early-stage life sciences companies, specifically at the pre-seed and seed stages. Their investment areas include human life science ventures such as medical devices, digital health, and diagnostics, while excluding therapeutics and drug development. VP Venture Partners seeks dedicated teams with a passion for bringing impactful products to market and provides hands-on support, including operational and strategic guidance.
Value beyond capital
VP Venture Partners adds value to its portfolio companies through hands-on support, operational and strategic guidance, and the ability to take interim C-level positions. This approach helps startups navigate challenges and accelerate their path to market.
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 9
Portfolio context
Notable portfolio companies include: Hemotune: Develops a blood purification platform using magnetic beads, combining biomedicine and nanotechnology. Xeltis: Creates artificial blood vessels and valves using the RestoreX™ platform, promoting self-healing. eMurmur®: An AI-powered platform for detecting and managing cardiovascular and respiratory diseases. BC Platforms: Provides real-world data solutions for life science and healthcare organizations. Luciole Medical: Offers brain monitoring solutions across various hospital settings. Simulatory: Focuses on advanced simulation for surgical training. Recovery.cat: Develops digital therapy support for mental illness. ONWARD Medical: Works on therapies to restore movement in individuals with spinal cord injuries. Diamens: Utilizes menstrual blood to detect female-specific diseases.
Common questions
What to know about VP Venture Partners
Upseed classifies VP Venture Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.